Ledger.Open graph →
SEC Form D · Amendment · filed November 20, 2023

Cantai Therapeutics, Inc

Offering
$3.0M
Sold
$700K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Joshua Brandt · Philadelphia, PAExecGeeta Vemuri · Philadelphia, PAExec · DirectorRoss Leimberg · Philadelphia, PAExecErrik Anderson · Philadelphia, PAExec · DirectorJoshua Brandt · Philadelphia, PAExecErrik Anderson · Philadelphia, PAExec · DirectorGeeta Vemuri · Philadelphia, PAExec · DirectorRoss Leimberg · Philadelphia, PAExecCarole P. Nuechterlein · South San Francisco, CAExec · DirectorJames P. Scopa · South San Francisco, CAExec · DirectorMatthew Armendariz · Calabasas, CAExecDavid Swartz · Calabasas, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗